The Advanced Oncology/Hematology Drug Development Fellowship Program is designed for medical oncologists who desire additional fellowship training and clinical experience in clinical research with particular emphasis on early drug development methodology.
Institute of Drug Development fellows learn the clinical management of patients with advanced malignancies receiving treatment on Phase I clinical trials. This will include documentation necessary for clinical research subjects, the ethical aspects and regulatory process of informed consent as well as the capture of data including understanding the common toxicity criteria used in toxicity assessment. Our alumni are performing translational research into new drug development.
Medical school graduate accepted by Texas Medical Board or meets requirements set forth by Texas Higher Education Coordinating Board
If a foreign medical school graduate, must obtain J-1 training visa and ECFMG certificate
Meet eligibility criteria for Texas licence or a Physician in Training Permit issued by Texas Medical Board
Successfully completed postgraduate training in internal medicine and medical oncology/hematology, with added qualifications in medical oncology/hematology
An invaluable experience
The training gave me a behind-the-scenes look at the logistics required to organize, oversee and execute successful clinical trials. The experience and skills I learned are invaluable in my clinical practice.
Desiree Hao, Medical Oncology, Tom Baker Cancer Centre Associate Professor, Department of Oncology, University of Calgary